The manufacturing enterprise "Akademfarm" offers consumers the antiviral drug "Flustop Kids" for the treatment and prevention of influenza A and B in children aged 1 year and older under a manufacturing agreement and is seeking partners to enter into a distribution agreement.

Antiviral drugs for the treatment and prevention of influenza A and B in children 1 year and older play an important role in reducing the severity of the disease and preventing complications. These drugs are typically divided into neuraminidase inhibitors, M2 channel blockers, and direct-acting antivirals.

Major global manufacturers of antiviral drugs for the treatment and prevention of influenza A and B in children:

1. Roche (Switzerland)
- Drug: Oseltamivir (Tamiflu)
- Features: Tamiflu is approved for the treatment and prevention of influenza A and B in children 1 year and older. The drug is available in capsule and suspension forms for easy administration in children.
2. GlaxoSmithKline (GSK, UK)
- Drug: Zanamivir (Relenza)
- Features: Relenza is an inhaled drug used for the treatment and prevention of influenza A and B. It is approved for children over 5 years of age, but in some cases can be used in younger children under medical supervision.
3. Shionogi & Co., Ltd. (Japan)
- Product: Balaxavir marboxil (Xofluza)
- Features: Xofluza is a new antiviral drug for the treatment of influenza A and B, approved for children 12 years of age and older. Research is ongoing to expand its age range.
4. Natco Pharma (India)
- Product: Oseltamivir Generics
- Features: Manufacturer of high-quality generic oseltamivir for the treatment and prevention of influenza in children.
5. BioCryst Pharmaceuticals (USA)
- Product: Peramivir (Rapivab)
- Features: Rapivab is an injectable drug for the treatment of influenza A and B, approved for children 2 years of age and older.
6. Fujifilm Toyama Chemical (Japan)
- Product: Favipiravir (Avigan)
- Features: This drug is used in some countries to treat influenza, but its use in children is limited and requires further research.

There are also a large number of similar products available on the global market from manufacturers in various countries.

"Flustop Kids", manufactured by "Akadempharm", contains oseltamivir, which belongs to a group of drugs called neuraminidase inhibitors. These medications prevent the spread of the influenza virus in the body. They help relieve or prevent the development of influenza symptoms.
Influenza is an infection caused by a virus. Symptoms of influenza often include sudden fever (over 37.8°C), cough, runny or stuffy nose, headaches, muscle aches, and severe fatigue. These symptoms can also be caused by other infections. Influenza infection most often occurs during annual outbreaks (epidemics), when influenza viruses spread among the local population. Outside of epidemic periods, influenza symptoms are usually caused by another type of illness.

You can download information about the antiviral drug Flustop Kids from the Company's official website here.(in Russian)

In-house production. Highly qualified personnel.

International Nonproprietary Name: Oseltamivir

A medication with proven efficacy, included in influenza treatment protocols in the Republic of Belarus.
Approved for use for treatment and post-exposure prophylaxis in children aged 1 year and older.
Available in pediatric dosages of 30 mg and 45 mg for easy dosing.

The Republican production unitary enterprise "ACADEMPHARM" is a dynamically developing, science-intensive state-owned pharmaceutical company. Despite its young age in the pharmaceutical industry, "ACADEMPHARM" has already carved out a niche in the domestic market and continues to expand. The company focuses on unmet medical needs, expanding its product range annually.

Activities:
- Laboratory pharmaceutical research;
- Industrial production of medicinal products and other pharmaceuticals, vitamins, vitamin-mineral and metabolic complexes, and nutraceuticals;
- Contract pharmaceutical manufacturing.

Production lines are equipped with the latest equipment from leading global companies, meeting all GMP requirements.

The pharmaceutical quality system includes good manufacturing practices, quality control, and quality risk management. It is fully documented, and its effectiveness is monitored. All components of the quality system are staffed with competent personnel, sufficient facilities, equipment, and technical resources.

Official website of the Enterprise "Academpharm".

The Republican production unitary enterprise "AKADEMPHARM" holds national GMP (Good Manufacturing Practice) certificates for the production of all forms of its own products.

The company has implemented and operates a pharmaceutical quality system developed in accordance with the requirements of the national standard TKP 030-2017 (33050) "Good Manufacturing Practice" and international requirements.

Consumers interested in purchasing the antiviral drug "Flustop Kids" for the treatment and prevention of influenza A and B in children aged 1 year and older under a manufacturing agreement.

Partners interested in purchasing the antiviral drug "Flustop Kids" for the treatment and prevention of influenza A and B in children aged 1 year and older under a distribution services agreement.